Skip to content

Co-infections in Children Hospitalised for Bronchiolitis

Co-infections in Children Hospitalised for Bronchiolitis: Incidence, Clinical Symptoms and Influence of Cohort Isolation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01714076
Enrollment
172
Registered
2012-10-25
Start date
2012-11-30
Completion date
2015-10-31
Last updated
2015-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchiolitis

Brief summary

Observational cohort study in children hospitalized for acute bronchiolitis. Patients are nursed in cohort isolation. Aim is to investigate the incidence and clinical impact of co-infections in this group.

Detailed description

Observational cohort study in children hospitalized for acute bronchiolitis. Patients are nursed in cohort isolation, meaning that all patients admitted for bronchiolitis are cohorted together, irrespective of viral diagnosis. Aim is to investigate the incidence and clinical impact of co-infections in this group.

Interventions

OTHERcohort isolation

all patients hospitalised for bronchiolitis are nursed in one room together, separated from patients without bronchiolitis

Sponsors

Princess Amalia Children's Clinic
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 24 Months
Healthy volunteers
No

Inclusion criteria

* younger than 2 years admitted for bronchiolitis

Exclusion criteria

* chronic lung disease congenital heart defect down syndrome

Design outcomes

Primary

MeasureTime frameDescription
co-infectionapproximately 2 weeksco-infection acquired during hospitalisation, patient will be followed during hospitalisation and until 1 week after discharge from the hospital, since average duration of hospitalisation in infants with bronchiolitis is 3 days, the time frame will be approximately 2 weeks

Secondary

MeasureTime frameDescription
clinical severityapproximately 2 weeksclinical severity defined as, days of oxygen supplementation, tube feeding, dyspnea score, length of hospitalisation

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026